New drug that could save young leukaemia patients’ lives approved for NHS use

A potentially life-saving new treatment for children with a rare form of leukaemia is being made available on the NHS – but a drug for adults with blood cancer has been rejected.

The Scottish Medicines Consortium (SMC) has approved the use of Kymriah  – which is also known as tisagenlecleucel – for children and young people suffering from acute lymphoblastic lymphoma.

The SMC, which rules on the drugs that can be used on the NHS, said it “offers the possibility of long-term remission and is potentially a life-saving treatment option”.

Yescarta, which was approved…
Read more posts United Kingdom or read the original

This content was imported with an automated system, without human intervention. You can report the removal of content by first reading our Legal Disclaimer